에 대한 최신 뉴스 HOOKIPA Pharma (NASDAQ:HOOK) 주식

HOOKIPA Pharma

HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.

Government

Health Care

Retail Sales

Global

Startups

Small Business

AVGO

DKNG

HOOK

QCOM

SBGI

블록에 신규 등장 베라 브래들리(NASDAQ:VRA)의 매출이 감소했다. 이 핸드백 브랜드의 최대 주주인 Fund 1 Investments LLC는 이에 불만을 나타냈다. 12월 30일 이사회에 보낸 서한에서 공동 창립자인 바바라 브래들리 바엑가르드(Barbara Bradley Baekgaard)의 디자인을 &#34;상징적&#34;이고 &#34;수십 년간 혁신과 파괴의 대명사&#34;라고 언급했다.

딜 디스패치: 베라 브래들리는 명암이 혼재된 핸드백, 모델스의 전 CEO가 파티 시티를 탐색

HOOKIPA Pharma Inc

Hooker Furnishings Corporation - Common Stock

Hooker Furnishings Corp

WIIM

MCHP

Microchip Technology shares are trading higher after the company announced it launched an electric two-wheeler ecosystem.

Wall Street closed its <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44341328/stocks-enter-correction-zone-tariff-fears-hammer-consumer-confidence-inflation-worries-hit-32-year-highs-this-week-in-markets">fourth consecutive losing week</a>, its longest slide since May 2022. 
The S&amp;P 500 fell into correction territory, down 10% from its February highs. Investors continue to have anxiety over trade tensions and government spending cuts. While weaker-than-expected inflation data fueled hopes for Fed interest-rate reductions, markets still lingered on policy uncertainty from the White House. 
Nevertheless, despite overall market weakness, some ETFs performed better than the rest last week.
<h2 class="wp-block-heading">The Top Five Best-Performing ETFs </h2>
These ETFs highlight areas of opportunity amid broader volatility.
GraniteShares 2x Long INTC Daily ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTW#NASDAQ">INTW</a>): This <a href="https://www.benzinga.com/etfs">leveraged ETF </a>surged as Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) shares resumed their rise amid expectations of AI-supported chip demand.
<ul>
<li>Weekly Gains: 32.71%</li>
</ul>
<ul>
<li>Expense Ratio: 1.3%</li>
</ul>
Defiance Daily Target 2X Long SMCI ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCX#NASDAQ">SMCX</a>): Super Micro Computer&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) share rise, fueled by strong earnings and growing AI server demand, drove the return on this ETF.
<ul>
<li>Weekly Gains: 17.62%</li>
</ul>
<ul>
<li>Expense Ratio: 1.29%</li>
</ul>
T-Rex 2X Inverse Ether Daily Target ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ETQ#BATS">ETQ</a>): A pullback in Ethereum prices benefited this inverse ETF, which profits on downturns in the cryptocurrency.
<ul>
<li>Weekly Gains: 15.85%</li>
</ul>
<ul>
<li>Expense Ratio: 1.25%</li>
</ul>
T-Rex 2X Long NVIDIA Daily Target ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/NVDX#BATS">NVDX</a>): NVIDIA&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) continued dominance of the AI chip space pushed this leveraged ETF up.
<ul>
<li>Weekly Gains: 14.62%</li>
</ul>
<ul>
<li>Expense Ratio: 1.05%</li>
</ul>
Global X Silver Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIL#NYSE">SIL</a>): Rising silver prices, driven by safe-haven demand in times of economic uncertainty, boosted silver miners and this ETF.
<ul>
<li>Weekly Gains: 8.82%</li>
</ul>
<ul>
<li>Expense Ratio: 0.65%</li>
</ul>
<h2 class="wp-block-heading">What Moved The Markets Last Week</h2>
Investor anxiety is high as a result of pending trade tariffs under President Trump and sudden spending reductions spearheaded by the DOGE office under Elon Musk. Even softer-than-expected inflation readings—February&#8217;s CPI climbed 2.8% YoY, down from the 2.9% consensus—kept markets fixated on White House policy actions.
Trump vowed a 200% tariff on European wines if the EU drops its 50% tax on American whiskey and doubled tariffs on Canadian steel and aluminum, threatening auto tariffs.
Consumer confidence dropped and long-term inflation expectations reached their highest since 1993. In response to economic uncertainty, <a href="https://www.benzinga.com/etfs/specialty-etfs/25/03/44335436/gold-etfs-shine-as-spot-price-tops-3000-during-safe-haven-demand">gold hit a record $3,000 per ounce</a> and has increased in 10 of the last 11 weeks.
Markets bounced modestly at the end of the week on confirmation that a government shutdown would be averted and the lack of fresh trade news. The Federal Reserve is set to keep rates unchanged next week, although fears of stagflation—slowing growth coupled with ongoing inflation—are growing.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44332599/exclusive-what-industry-experts-are-saying-about-the-openai-oracle-nvidias-100b-stargate-project-etfs-that-stand-">Exclusive: What Industry Experts Are Saying About OpenAI-Oracle-Nvidia&#8217;s $100-Billion Stargate Project &amp; ETFs That Stand To Gain</a></li>
</ul>
Image: Shutterstock

Broad U.S. Equity ETFs

ETFs

INTC

INTW

NVDA

ETF Opportunities Trust T-Rex 2X Long NVIDIA Daily Target ETF

NVDX

SMCI

SMCX

Wall Street's Losing Streak Deepens, But These 5 ETFs Defy The Slump

All eyes are on NVIDIA Corp.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) GTC 2025. <a href="https://www.benzinga.com/topic/jensen-huang">CEO Jensen Huang</a> is set to unveil what's next <a href="https://www.benzinga.com/topic/artificial-intelligence">in AI hardware</a>.
JPMorgan analyst Samik Chatterjee outlines key watchpoints, as investors dissect the event for winners and losers across the hardware and networking supply chain.
<h1 class="wp-block-heading">Blackwell Ultra: On Track, But Skepticism Remains</h1>
Chatterjee expects "Blackwell Ultra ramp remains on track for the second half of the year" — a crucial milestone for Nvidia suppliers. Investors are "likely to be taken as a positive" only if Nvidia reaffirms its aggressive innovation cycle. 
The Rubin platform, expected in 2026, will also be in focus, though "specificity on timing" may be lacking.
Among the potential winners? 
Super Micro Computer Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), Dell Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>), Coherent Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>), Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) and Amphenol Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) are all poised to benefit from Nvidia's hardware evolution.
Read Also: <a href="https://www.benzinga.com/tech/25/03/44352209/gtc-2025-could-reignite-nvidias-stock-rally-but-only-if-b300-ai-server-roadmap-and-scaling-concerns-are-addressed-says-top-analyst">GTC 2025 Could Reignite Nvidia&#8217;s Stock Rally, But Only If B300, AI Server Roadmap, And Scaling Concerns Are Addressed, Says Top Analyst</a>
<h1 class="wp-block-heading">How Dell, Super Micro Stand To Gain</h1>
The next-gen chips will push power and thermal limits. Blackwell Ultra and Rubin will demand "independent power racks (300-700 kW per rack)" and more liquid cooling. This should benefit Dell and Super Micro. 
At the GTC 2025, one may also expect heightened interest in "increasing GPU density" and rising thermal design power levels: 1.2 kW for Blackwell, 1.4 kW for Blackwell Ultra and 1.8 kW for Rubin.
<h1 class="wp-block-heading">Copper Vs. Optics: Amphenol, Coherent, Fabrinet Likely Winners</h1>
Networking firms will be under the microscope as rack density rises from 36 to 72 to 144 GPUs. While optics adoption is a concern, "connectivity within the rack to be dominated by copper" is good news for Amphenol. 
Optical transceiver suppliers like Coherent and Fabrinet are positioned well as "resilient transceiver ASPs" hold steady amid short innovation cycles.
<h1 class="wp-block-heading">Investor Sentiment: AI Capex Uncertainty Looms</h1>
While GTC may not settle broader AI capex concerns, it could "primarily change sentiment" on key AI supply chain stocks. Amphenol, with its passive copper exposure, and optical transceiver names like Fabrinet, Lumentum and Coherent will be in the spotlight.
With Nvidia's GTC just weeks away, the stakes are high. For hardware and networking stocks, the AI boom is far from over. Investors will be tuning in to see who rides the next wave.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44360400/legendary-trader-says-tesla-nvidia-apple-shares-are-ready-to-rally-i-see-what-i-like-to-see">Legendary Trader Says Tesla, Nvidia, Apple Shares Are Ready To Rally: &#8216;I See What I Like To See&#8217;</a></li>
</ul>

Analyst Color

Long Ideas

News

Events

Analyst Ratings

Tech

Trading Ideas

COHR

DELL

Why Nvidia's Next Moves Matter For Amphenol, Dell, Super Micro

Citigroup analyst Nick Joseph maintains Cushman &amp; Wakefield (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWK#NYSE">CWK</a>) with a Neutral and lowers the price target from $16 to $12.

Price Target

Citigroup Maintains Neutral on Cushman & Wakefield, Lowers Price Target to $12

Sprouts Farmers Market shares are trading higher after Deutsche Bank upgraded the stock from Hold to Buy and raised its price target from $163 to $190.

Citigroup analyst Nick Joseph maintains Host Hotels &amp; Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HST#NASDAQ">HST</a>) with a Buy and lowers the price target from $21 to $19.

Citigroup Maintains Buy on Host Hotels & Resorts, Lowers Price Target to $19

Citigroup analyst Nick Joseph maintains Kimco Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KIM#NYSE">KIM</a>) with a Neutral and lowers the price target from $27 to $21.

Citigroup Maintains Neutral on Kimco Realty, Lowers Price Target to $21

Royal Gold's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGLD#NYSE">RGLD</a>) short percent of float has risen 8.82% since its last report. The company recently reported that it has 1.62 million shares sold short, which is 3.7% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.89 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Royal Gold Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742236229_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Royal Gold has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Royal Gold's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Royal Gold's peer group average for short interest as a percentage of float is 3.82%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

RGLD

What Does the Market Think About Royal Gold?

Renasant's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNST#NYSE">RNST</a>) short percent of float has risen 5.5% since its last report. The company recently reported that it has 5.28 million shares sold short, which is 11.12% of all regular shares that are available for trading. Based on its trading volume, it would take traders 10.11 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Renasant Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742236224_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Renasant has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Renasant's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Renasant's peer group average for short interest as a percentage of float is 4.27%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

RNST

What Does the Market Think About Renasant?

CSX's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NYSE">CSX</a>) short percent of float has risen 4.48% since its last report. The company recently reported that it has 26.52 million shares sold short, which is 1.4% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.82 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>CSX Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742236219_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CSX has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing CSX's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, CSX's peer group average for short interest as a percentage of float is 7.93%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About CSX?

Gorilla Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) shares are trading lower on Monday after Citron Research made comments on social media <a href="https://www.benzinga.com//node/44358292">criticizing the company.</a>
The Details: Citron <a href="https://x.com/CitronResearch/status/1901649333084140025">called</a> for the Securities and Exchange Commission to halt trading of Gorilla shares, invoking Rule 10b-5, which prohibits false or misleading statements or omissions of material facts that could deceive investors.
The short-selling firm initially referenced a recent <a href="https://www.benzinga.com//node/44299637">press release</a> from the company, which highlighted a deal worth hundreds of billions with Renato da Cruz Costa. Citron asserts that Costa is involved in at least 18 lawsuits in Brazil, including some related to embezzlement and financial default, as reported by Brazilian media.
Citron noted that if the individual in question is a different Renato Costa, it apologizes, but it maintains that the company&#8217;s claims are questionable.
The firm also questioned Gorilla Technlogy CEO&#8217;s claims that its upcoming token valuation will reach trillions. Additionally, it questioned how analysts can endorse a company that declares itself a global leader in AI-driven solutions while its Research and Development spending is minimal.
Benzinga has reached out to Gorilla for comment on the matter.
Related Link: <a href="https://www.benzinga.com/general/health-care/25/03/44359600/hyperfine-nvidia-partner-to-make-brain-mris-more-affordable">Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable</a>
GRRR Price Action: At the time of writing, Gorilla shares are trading 9.3% lower at $30.44, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: This illustration was generated using artificial intelligence via Midjourney.

Movers

GRRR

What's Going On With Gorilla Technology Stock Monday?

Citigroup analyst Kyle Menges maintains Terex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEX#NYSE">TEX</a>) with a Neutral and lowers the price target from $48 to $45.

Citigroup Maintains Neutral on Terex, Lowers Price Target to $45

President Donald Trump's tax reduction plans, paired with his aggressive tariff policies, have significantly disrupted the cryptocurrency market, prompting heightened volatility and an <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44359400/bitcoin-etfs-see-record-5-5-billion-in-outflows-in-5-weeks-as-tariff-turbulence-looms">ETF-driven sell-off</a> in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) over the past weeks.
<h2 class="wp-block-heading">Donald Trump&#8217;s Tax Plans&#8230;</h2>
Trump's proposal to <a href="https://www.benzinga.com/markets/25/03/44295365/trump-wants-no-tax-for-americans-making-less-than-150000-a-year-says-howard-lutnick-thats-what-im-working-for">eliminate income tax for individuals</a> earning less than $150,000—potentially affecting 93% of Americans—aims to boost disposable income, but his simultaneous tariff hikes, including a 20% universal rate and 60% on Chinese imports, have sparked inflation fears, impacting risk assets like cryptocurrencies.
The interplay of these policies, alongside the <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43889897/bitcoin-strategic-reserve-with-1-million-btc-could-offset-21-trillion-national-debt">Strategic Bitcoin Reserve</a>, has created a complex landscape for crypto investors.
Trump's tax strategy includes making the 2017 Tax Cuts and Jobs Act (TCJA) permanent, which lowered the top income tax rate from 39.6% to 37%, and now extends to exempting incomes below $150,000, as well as tips, overtime pay and Social Security benefits, per Tax Foundation data.
Commerce Secretary Howard Lutnick, in a CBS News interview on March 12, <a href="https://www.youtube.com/watch?v=irDuJt9dINo">emphasized </a>that these measures "generate revenue and drive growth," potentially freeing up funds for Americans to invest in assets like Bitcoin.
But the revenue shortfall, <a href="https://budgetmodel.wharton.upenn.edu/issues/2025/2/27/fy2025-house-budget-reconciliation-and-trump-tax-proposals-effects">estimated </a>at $4.9 trillion over a decade by the Penn Wharton Budget Model, is meant to be offset by tariffs, which could raise $3.3 trillion but may also shrink GDP and fuel inflation, as warned by the Peterson Institute for International Economics.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44359400/bitcoin-etfs-see-record-5-5-billion-in-outflows-in-5-weeks-as-tariff-turbulence-looms">Bitcoin ETFs See Record $5.5 Billion In Outflows In 5 Weeks As Tariff Turbulence Looms</a>
<h2 class="wp-block-heading">&#8230;And What They Mean For Crypto</h2>
The crypto market has felt immediate effects: Bitcoin dropped from $105,000 to $92,000 (-12.38%) after the Feb. 1 tariff threat and rebounded to $100,000 (+8.7%) on Feb. 3 with a Mexico tariff pause.
It fell from $94,834 to $86,500 (-8.79%) on the March 3 tariff confirmation, hit $78,225 (-14.45%) by the March 5 post-implementation, and dumped 5% from $89,200 to $84,600 after the March 7 Bitcoin Reserve signing.
By March 17, Bitcoin had slid from $109,000 to $85,000 (-13.68%) amid ongoing tariff impacts.
U.S. Bitcoin ETFs saw record outflows of $5.5 billion over five weeks, reflecting investor caution amid trade war fears, according to Bloomberg. 
Greg Magadini, director of derivatives at Amberdata, noted, "Bitcoin and crypto overall remain driven by the macro picture right now. I don't expect Bitcoin to diverge from risk-assets for the time being."
<h2 class="wp-block-heading">The Role Of The Strategic Bitcoin Reserve</h2>
Meanwhile, Trump's <a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44184474/trump-announced-strategic-bitcoin-reserve-to-allow-buying-additional-btc-peter-schiff-doesnt-think-so-but-heres-what-the-order-says">Strategic Bitcoin Reserve</a>, established on March 6 with 200,000 BTC worth $17 billion from seized assets, has bolstered Bitcoin's legitimacy, potentially supporting prices long-term, as reported by Reuters.
Despite this, the tariff-driven economic uncertainty has overshadowed the reserve's positive signal, with inflation risks making Bitcoin a potential hedge but also causing short-term volatility. 
"Tariffs could lead to inflation, making Bitcoin attractive as a hedge, but initial market reactions show volatility," according to an ABC News analysis. 
The broader crypto market, including assets like Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) and Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) in the U.S. Digital Asset Stockpile, may also see increased interest if economic instability persists, though trade wars could dampen overall investor sentiment, as highlighted by the Stanford Institute for Economic Policy Research.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44358584/strategy-purchases-130-more-bitcoin-now-holds-over-499000-btc">Strategy Purchases 130 More Bitcoin, Now Holds Over 499,000 BTC</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$SOL

Will Bitcoin Go Up If Donald Trump Eliminates Income Tax For Americans Making Less Than $150,000?

William Blair initiated coverage on Butterfly Network Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NASDAQ">BFLY</a>), a digital health company that provides portable, semiconductor-based ultrasound technology <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">and intuitive software</a>.
The company reported a fourth-quarter adjusted loss of 5 cents per share, beating the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of 10 cents</a>.
Sales increased 35% year over year to $22.35 million, beating the consensus of $21.97 million, driven by the recently launched next-generation iQ3 probe&#8217;s higher selling price and <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b44038034/butterfly-network-reports-fourth-quarter-2024-financial-results" rel="noreferrer noopener">increased enterprise software revenue</a>.
Product revenue was $14.7 million, an increase of 45% versus the prior year period, driven by the 22% increase in units fulfilled year-over-year and the iQ3&#8217;s higher selling price.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/03/44359442/protalix-biotherapeutics-says-with-debt-fully-repaid-its-well-positioned-to-execute-strategy-through-2025-and-beyond" rel="noreferrer noopener">Protalix BioTherapeutics Says With Debt Fully Repaid, It&#8217;s Well-Positioned To Execute Strategy Through 2025 And Beyond</a>
Butterfly Network expects 2025 sales of $96 million—$100 million, compared to a consensus of $97.80 million and an adjusted EBITDA loss of $37 million—$42 million.
&#8220;Butterfly is pioneering the digital ultrasound market, democratizing access to imaging and expanding its total addressable market (TAM),&#8221; William Blair writes. &#8220;The valuation ascribes only some success in the core point-of-care and hospital markets, but with execution on growth objectives, we believe shares can rise meaningfully.&#8221;
Analyst Andrew Brackmann <a href="https://www.benzinga.com/quote/BFLY/analyst-ratings" target="_blank" rel="noreferrer noopener">initiates with an Outperform</a> rating and notes that the company&#8217;s core business can grow roughly 20% over the next several years and likely closer to a low-to-mid-teens revenue compound annual rate between 2024 and 2030.
The William Blair analyst writes Butterfly&#8217;s homecare business has strong potential to boost revenue and expand market opportunities over the next 12 to 24 months.
While still in its early stages, the analyst sees it as a key growth driver that could become a multi-hundred-million-dollar business within five years. Despite this potential, the share price does not yet reflect these efforts.
Price Action: BFLY stock is up 2.05% at $2.74 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44358669/energy-vault-strengthens-australian-presence-with-220-million-acquisition-of-stoney-creek" target="_blank" rel="noreferrer noopener">Energy Vault Strengthens Australian Presence With Stoney Creek Deal: Details</a></li>
</ul>
Photo: Shutterstock

Initiation

General

BFLY

Butterfly Network Is 'Pioneering Digital Ultrasound Market,' Analyst Says Undervalued Stock Could Rise With Growth Execution

Citigroup analyst Ronald Josey maintains trivago (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVG#NASDAQ">TRVG</a>) with a Neutral and raises the price target from $2.6 to $4.5.

TRVG

Citigroup Maintains Neutral on trivago, Raises Price Target to $4.5

Citigroup analyst Kelly Crago maintains Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) with a Neutral and lowers the price target from $405 to $365.

ULTA

Citigroup Maintains Neutral on Ulta Beauty, Lowers Price Target to $365

CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) is flashing a bullish signal as it completes <a href="https://www.benzinga.com/topic/golden-cross">a Golden Cross</a> — an event where the 50-day simple moving average (SMA) rises above the 200-day SMA. 
With the stock up over 51% year to date and continuing to trade above key moving averages, technicals suggest further upside.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="618" height="487" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/17133310/Screenshot-2025-03-17-at-5.08.30-PM.png" alt="" class="wp-image-827853" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/17133310/Screenshot-2025-03-17-at-5.08.30-PM.png 618w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/17133310/Screenshot-2025-03-17-at-5.08.30-PM-300x236.png 300w" sizes="(max-width: 618px) 100vw, 618px" /></a></figure>
<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
Adding to investor enthusiasm, CVS's weight management program has delivered an average 15% weight loss for participants while cutting costs by 26%.
Read Also: <a href="https://www.benzinga.com//node/44346604">Allegations of Inflated Prescription Drug Costs Spark Employee Lawsuit Against JPMorgan</a>
<h2 class="wp-block-heading">CVS Stock Technicals Point To Strength</h2>
Several technical signals confirm CVS stock's strong uptrend:
<ul>
<li>Golden Cross Formation: The 50-day SMA ($57.86) has officially crossed above the 200-day SMA ($57.72), reinforcing a bullish outlook.</li>
<li>Momentum Stays Strong: CVS stock trades above its eight-day, 20-day and 50-day SMAs, confirming sustained buying pressure.</li>
<li>Moving Average Covergence/Divergence (MACD) Indicator: At 2.01, the MACD remains in bullish territory, signaling strong upward momentum.</li>
<li>Relative Strength Index (RSI): The RSI at 62.46, is nearing overbought territory, indicating that CVS stock remains in a strong trend, though some profit-taking could occur.</li>
</ul>
<h2 class="wp-block-heading">CVS Weight Loss Program Gains Traction</h2>
On the fundamental side, CVS reported that its Weight Management program led to an average 15% weight loss among participants and a 26% reduction in weight-loss drug costs. The program, which integrates GLP-1 medications with personalized nutrition plans, has been rolled out to 3.5 million members.
CVS stock has been riding this wave of positive news and strong technicals. The golden cross suggests continued bullish momentum, though with RSI creeping higher, short-term volatility could emerge. If buying pressure remains, CVS could see further gains in the coming weeks.
Related: 
<ul>
<li><a href="https://www.benzinga.com//node/44336874">CVS Weight Management Program Yields 15% Average Weight Loss, 26% Cost Saving Among Participants</a></li>
</ul>
Image: Shutterstock

Technicals

Signals

CVS Stock Flashes Golden Cross As Weight Loss Program Delivers Big Results

Citigroup analyst Paul Lejuez maintains Kohl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) with a Neutral and lowers the price target from $11 to $8.

Citigroup Maintains Neutral on Kohl's, Lowers Price Target to $8

Citigroup analyst Paul Lejuez maintains Academy Sports (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>) with a Buy and lowers the price target from $65 to $60.

Citigroup Maintains Buy on Academy Sports, Lowers Price Target to $60

Small Cap Consumer Research analyst Eric Beder reiterated a <a href="https://www.benzinga.com/quote/LE/analyst-ratings">Buy rating </a>on the shares of Lands End Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LE#NASDAQ">LE</a>) with a price forecast of $20.00 after reviewing the March catalog.
Lands&#8217; End&#8217;s March catalog highlights the start of the swim season, with over 40% of the 80-page catalog dedicated to swimwear and related items.
Themed &#8220;The Power of Pretty,&#8221; the catalog marks a significant step in developing a lifestyle-driven publication that offers complete looks across multiple categories.
Featuring everyday models, it allows customers to easily envision themselves in the brand's offerings. This approach targets a younger customer base and is expected to reduce heavy discounting on key items. 
Also Read: <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44356299/why-is-clothing-firm-guess-stock-surging-today">Why Is Clothing Firm Guess Stock Surging Today?</a>
The Lands&#8217; End catalog has transitioned from a sales-driven approach to one focused on emotional appeal. There is an increasing emphasis on multi-category styles that prioritize the overall look rather than pricing, said the analyst.
Starting with simple styles at the beginning of 2024, Lands&#8217; End has broadened its selection of bottoms to include denim and a new soft polish collection. This category now presents a significant growth opportunity for the brand.
According to the analyst, The emphasis on rain-ready outerwear has grown, with the lightweight Squall taking the lead, replacing the Wanderweight down styles from 2024. 
Meanwhile, footwear remains a standout, with popular Spring flats and slingbacks stealing the spotlight. Overall, the company's strategy is seen as strengthening its position in the market, asserted the analyst.
Price Action: LE shares traded higher by 2.55% at $11.05 at last check Monday.
Read Next: <a href="https://www.benzinga.com/general/health-care/25/03/44359600/hyperfine-nvidia-partner-to-make-brain-mris-more-affordable">Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable</a>
Photo: Shutterstock

Reiteration

Lands' End Strengthens Catalog Strategy To Embrace Younger Audience, Says Analyst

Press Releases

Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm

HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset

HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer

HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024

HOOKIPA Pharma's Eseba-vec Highlighted in SITC Late-Breaker

Earnings

HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates

HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements

HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV

ABVC BioPharma

Aprea Therapeutics

BioCardia

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

Bolt Biotherapeutics, Inc. - Common Stock

Bolt Biotherapeutics

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Eterna Therapeutics

Evaxion Biotech A/S - American Depositary Share

Evaxion Biotech

Geovax Labs

HCW Biologics

Imunon

IN8bio

Kairos Pharma

Leap Therapeutics

MEI Pharma

Marker Therapeutics

MetaVia

BiomX

SAB Biotherapeutics

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Sensei Biotherapeutics, Inc. - Common Stock

Sensei Biotherapeutics

Senti Biosciences

Spruce Biosciences

Synlogic

RBC Capital

JMP Securities

Truist Securities

Morgan Stanley

<h1 class="wp-block-heading">블록에 신규 등장</h1>
베라 브래들리(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>)의 <a href="https://www.benzinga.com/24/12/42439021/vera-bradley-reports-30-sales-drop-in-q3-amid-business-model-transition-stock-slips">매출이 감소</a>했다.
이 핸드백 브랜드의 최대 주주인 Fund 1 Investments LLC는 이에 불만을 나타냈다. 12월 30일 <a href="https://www.businesswire.com/news/home/20241230656224/en/Fund-1-Sends-Letter-to-Vera-Bradley%E2%80%99s-Board-of-Directors-Highlighting-the-Opportunity-for-Value-Enhancing-Strategic-Alternatives">이사회에 보낸 서한</a>에서 공동 창립자인 바바라 브래들리 바엑가르드(Barbara Bradley Baekgaard)의 디자인을 &#8220;상징적&#8221;이고 &#8220;수십 년간 혁신과 파괴의 대명사&#8221;라고 언급했다.
하지만 칭찬 뒤에는 비판이 이어졌다. Fund 1은 베라 브래들리의 자본 배분 문제, 열악한 운영 성과 및 실패한 브랜드 전환 그리고 패션 브랜드에 대한 어려운 거시 경제적 조건을 문제 삼았다. Fund 1의 해결책은 무엇일까? &#8220;전략적 대안 프로세스&#8221;를 통해 이 회사를 더 큰 조직에 매각하거나 비공개로 전환하는 것이다.
이번 주에 매물로 나온 것들:
<ul>
<li>영국의 반도체 및 소프트웨어 설계 회사로 사모펀드 캐넌 브리지 캐피털 파트너스(Canyon Bridge Capital Partners) 소속의 이매지네이션 테크놀로지 그룹(Imagination Technologies Group Limited)이 매각을 진행 중이다. 라자드(Lazard)가 매각을 주선하고 있다고 <a href="https://www.bloomberg.com/news/articles/2025-01-03/chipmaker-imagination-s-owners-tap-lazard-to-search-for-buyer?srnd=phx-deals">블룸버그</a>가 보도했다.</li>
<li>스킨 케어 스타트업 미니멀리스트(Minimalist)가 3억 5천만 달러 규모의 인수합병을 검토 중이라고 <a href="https://techcrunch.com/2025/01/03/hindustan-unilever-minimalist-acquisition/?guccounter=1">테크크런치</a>가 보도했다. 매수자는 최근 오지바(Oziva)와 웰빙 뉴트리션(Wellbeing Nutrition)을 인수한 힌두스탄 유니레버(Hindustan Unilever Ltd.)이다. 힌두스탄 유니레버의 스킨케어 제품에는 도브(Dove)와 폰즈(Pond&#8217;s)가 포함되어 있다. 자이푸르에 본사를 둔 미니멀리스트는 2024 회계연도에 4,080만 달러의 매출을 기록하며 89% 성장했다.</li>
</ul>
<h1 class="wp-block-heading">블록에서 제외</h1>
사우스스테이트(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSB#NYSE">SSB</a>)가 텍사스 기반의 인디펜던트 뱅크 그룹(Independent Bank Group)을 20억 달러에 인수하며 지역 은행 합병 물결을 예고했다. 주요 요인은 지역 은행 주가 상승, 금리 인하로 인한 예금 수익성 개선 그리고 트럼프 행정부 하의 규제 완화 기대이다.
후키파 파마(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOK#NASDAQ">HOOK</a>)가 풀벡 파마(Poolbeg Pharma)를 전액 주식 거래로 인수하고 있다. 후키파 주주들은 길리어드(Gilead)의 B형 간염 파트너십에서 발생하는 이정표 지급금과 HB-200 프로그램의 수익에 대한 권리를 유지한다.
참고: <a href="https://kr.benzinga.com/news/usa/stocks/%EC%8A%A4%ED%83%A0%EB%A6%AC-%EB%93%9C%EB%9F%AC%EC%BC%84%EB%B0%80%EB%9F%AC-%ED%8A%B8%EB%9F%BC%ED%94%84-%EB%8B%B9%EC%84%A0-%EC%A0%84%EC%97%90-%EC%A7%80%EC%97%AD-%EC%9D%80%ED%96%89-%EC%A3%BC%EC%8B%9D/" target="_blank" rel="noopener">스탠리 드러켄밀러, 트럼프 당선 직전 지역 은행 주식 매수</a>
<h1 class="wp-block-heading">파산 블록</h1>
미치 모델(Mitch Modell), 모델스(Modell&#8217;s) 스포츠 용품 체인의 전 CEO가 파산한 소매업체 파티 시티(Party City)와 빅랏츠(Big Lots)를 재건하고자 한다. 그는 10억 달러를 모금하고 33,000개의 일자리를 지킬 계획이다. <a href="https://nypost.com/2024/12/30/business/former-modells-owner-wants-to-save-bankrupt-retailers-party-city-big-lots-our-goal-is-to-save-33k-jobs/">뉴욕 포스트</a>에 따르면, 또한 자신의 20대 아들인 매튜(Matthew)와 맥스웰(Maxwell)을 공동 사장으로 임명하고 싶어한다.
모델은 &#8220;Gotta go to Mo&#8217;s&#8221;라는 캐치프레이즈로 유명하며, 마러라고에서 어려움을 겪고 있는 체인점에 스포츠 용품의 멋을 더해야 한다고 생각하게 되었다. 그의 비전은 빅랏츠의 부피 큰 가구를 없애고 파티 시티를 스포츠웨어와 운동화로 화려하게 꾸미는 것이다. &#8220;생일 축하해!&#8221;보다 새로운 운동화 한 켤레가 더 좋지 않나?
가격을 낮게 유지하기 위해 모델은 소스 원 글로벌(Source One Global)을 통해 중국, 멕시코 및 인도에 있는 공장을 활용할 계획이다. 그는 또한 래리 메이어(Larry Meyer) (포에버 21)와 데모스 파네로스(Demos Parneros) (반스앤노블)와 같은 다른 전 CEO들을 영입하여 거래를 평가하도록 했다.
<h1 class="wp-block-heading">블록의 메모</h1>
2025년, 새로운 트럼프 행정부는 합병을 추진하는 미디어 대기업에 더 우호적일 것으로 예상되며, 이는 바이든 행정부와 비교된다. &#8220;M&amp;A 관점에서 압도적인 분위기가 긍정적이다&#8221;고 크리스토퍼 볼머(Christopher Vollmer), 미디어링크(MediaLink)의 전무가 <a href="https://variety.com/2025/biz/news/media-mergers-acquisitions-2025-deals-1236263982/">버라이어티</a>에 말했다. &#8220;사람들은 2025년 1분기에 M&amp;A 활동을 시작하기를 원한다.&#8221;
하지만 사람들은 트럼프가 지난번 집권 기간 동안 거래제안자들에게 그리 우호적이지 않았다는 사실을 잊는다. 2016년부터 2020년까지의 이전 트럼프 행정부는 많은 대형 거래를 차단하고 소송을 제기하거나 차단하겠다고 위협했다.
기억하겠습니까:
<ul>
<li>AT&amp;T(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>)와 타임 워너 <a href="https://www.benzinga.com/news/17/11/10748659/at-t-resists-doj-order-to-divest-time-warners-cnn-for-merger-approval">합병을 성사시키지 못했다</a>. 규제 당국은 이것이 소비자 가격을 인상하고 경쟁업체 유통업체에 불리하게 작용할 수 있다고 주장했다.</li>
<li>싱클레어(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBGI#NASDAQ">SBGI</a>)와 트리뷴 미디어는 방송 산업의 통합에 대한 우려로 저항에 직면했다. 싱클레어는 <a href="https://www.benzinga.com/m-a/24/11/41805370/jim-cramer-hopes-m-a-to-come-back-bigly-under-trump-administration">헐값을 치뤘다</a>.</li>
<li>브로드컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>)과 퀄컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>)이 합병하면 미국 국가 안보에 영향을 미칠 수 있다는 연방 <a href="https://www.investors.com/news/technology/broadcom-buyout-of-qualcomm-looking-doubtful-after-federal-probe/">조사 결과</a>가 나왔다.</li>
<li>드래프트킹스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>)와 팬듀얼: 일일 환상 스포츠 플랫폼 2개가 합병되는 것은 업계의 경쟁을 유지하기 위해 차단되었다.</li>
</ul>
법무부는 주요 거래에서 분할을 의무화하기도 했다. 예를 들어:
<ul>
<li>브리스톨-마이어스 스퀴브(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>)는 셀진(Celgene)의 오테즐라 치료제를 매각해야 했다. 이는 시장에서의 경쟁 감소에 대한 우려를 해소하기 위한 조치였다.</li>
<li>해리스는 L3 테크놀로지스와의 합병을 진행하기 위해 군 통신 사업 부문의 일부를 매각해야 했으며, 이로 인해 L3해리스 테크놀로지스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>)가 탄생했다.</li>
</ul>
이러한 개입은 시장 지배력 방지에 대한 DOJ의 초점을 반영했다. 트럼프 하에서 M&amp;A 볼륨이 지난 4년과 비슷하다면, 거래 전문가들은 아무도 자신들을 탓할 수 없을 것이다.
지난주의 ‘딜 디스패치'에 대한 자세한 내용은 <a href="https://kr.benzinga.com/news/usa/stocks/%EB%94%9C-%EB%94%94%EC%8A%A4%ED%8C%A8%EC%B9%98-%ED%8C%8C%ED%8B%B0-%EC%8B%9C%ED%8B%B0-%EB%A7%88%EB%AC%B4%EB%A6%AC-%EB%B9%85%EB%9E%8F%EC%B8%A0-%ED%8C%8C%EC%82%B0-%EB%8D%94-%EC%BB%A8%ED%85%8C%EC%9D%B4/" target="_blank" rel="noopener">여기를 클릭하세요.</a>
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

HOOKIPA Pharma

뉴스

에 대한 최신 뉴스 HOOKIPA Pharma (NASDAQ:HOOK) 주식

토요일, 1월 04, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌